SPY345.78+1.17 0.34%
DIA283.34-0.31 -0.11%
IXIC11,548.28+42.28 0.37%

Morgan Stanley Maintains Underweight on Ionis Pharmaceuticals, Lowers Price Target to $50

Morgan Stanley maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Underweight and lowers the price target from $54 to $50.

· 10/13/2020 09:55
Morgan Stanley maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Underweight and lowers the price target from $54 to $50.